InvestorsHub Logo
Followers 271
Posts 53131
Boards Moderated 3
Alias Born 08/16/2008

Re: None

Tuesday, 05/23/2023 8:18:33 AM

Tuesday, May 23, 2023 8:18:33 AM

Post# of 22
AVRO "This transaction strengthens AVROBIO's balance sheet, focuses our pipeline strategy and is a strong endorsement of our HSC gene therapy approach and plato® gene therapy platform," AVRO's chief executive Erik Ostrowski remarked.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.